Infiltrative Astrocytomas (Diffuse Astrocytoma, Anaplastic Astrocytoma, Glioblastoma)

  • Christine E. Fuller


Infiltrative astrocytomas represent a diverse group of glial tumors of variable degree of malignancy that share in common the qualities of astrocytic differentiation and an inherent ability to diffusely invade CNS parenchyma.


Diffuse astrocytoma Anaplastic astrocytoma Glio­blastoma 

Suggested Reading

  1. Fisher PG, Breiter SN, Carson BS, Wharam MD, Weingart JD, Foer DR et al (2000) A clinicopathologic reappraisal of brain stem tumor classification. Cancer 89:1569–1576PubMedCrossRefGoogle Scholar
  2. Raffel C, Frederick L, O’Fallon JR, Atherton-Skaff P, Perry A, Jenkins RB et al (1999) Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin Cancer Res 5:4085–4090PubMedGoogle Scholar
  3. Sung T, Miller DC, Hayes RL, Alonso M, Yee H, Newcomb EW (2000) Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Pathol 10(2):249–259PubMedCrossRefGoogle Scholar
  4. Giannini C, Scheithauer BW (1997) Classification and grading of low-grade astrocytic tumors in children. Brain Pathol 7:785–798PubMedCrossRefGoogle Scholar
  5. Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M (1995a) Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 82(4):536–547PubMedCrossRefGoogle Scholar
  6. Sure U, Ruedi D, Tachibana O, Yonekawa Y, Ohgaki H, Kleihues P et al (1997) Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol 56(7):782–789PubMedGoogle Scholar
  7. Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL et al (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346:420–427PubMedCrossRefGoogle Scholar
  8. Pollack IF, Finkelstein SD, Burnham J, Holmes EJ, Hamilton RL, Yates AJ et al (2001) Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res 61:7404–7407PubMedGoogle Scholar
  9. Felix CA, Slave I, Dunn M, Strauss EA, Phillips PC, Rorke LB et al (1995) p53 gene mutations in pediatric brain tumors. Med Pediatr Oncol 25(6):431–436PubMedCrossRefGoogle Scholar
  10. Broniscer A, Baker SJ, West AN, Fraser MM, Proko E, Kocak M et al (2007) Clinical and molecular characterization of malignant transformation of low-grade glioma in children. J Clin Oncol 25(6):682–689PubMedCrossRefGoogle Scholar
  11. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC, LyonGoogle Scholar
  12. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T et al (2007) Molecular pathogenesis of pediatric astrocytic tumors. Neurooncol 9:113–123PubMedCrossRefGoogle Scholar
  13. Wolff JE, Classen CF, Wagner S, Kortmann RD, Palla SL, Pietsch T et al (2008) Subpopulation of malignant gliomas in pediatric patients: analysis of the HIT-GLIOBLASTOMA database. J Neurooncol 87(2):155–164PubMedCrossRefGoogle Scholar
  14. Thorarinsdottir HR, Santi M, McCarter R, Rushing EJ, Cornelison R, Jales A et al (2008) Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas. Clin Cancer Res 14(11):3386–3394PubMedCrossRefGoogle Scholar
  15. Daglioglu E, Cataltepe O, Akalan N (2003) Tectal gliomas in children: the implications for natural history and management strategy. Pediatr Neurosurg 38(5):223–231PubMedCrossRefGoogle Scholar
  16. Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M (1995b) Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 82(4):536–547PubMedCrossRefGoogle Scholar
  17. Bowers DC, Georgiades C, Aronson LJ, Carson BS, Weingart JD, Wharam MD et al (2000) Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg 32(1):24–29PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Christine E. Fuller
    • 1
  1. 1.Department of PathologyVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations